These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 39256259)
1. Effectiveness of dexamethasone implants in treating diabetic macular edema with hard exudates: a clinical observation. Zhao S; Liang X; Zhang J Int Ophthalmol; 2024 Sep; 44(1):377. PubMed ID: 39256259 [TBL] [Abstract][Full Text] [Related]
2. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema. Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215 [TBL] [Abstract][Full Text] [Related]
3. Title: efficacy of intravitreal dexamethasone implant on hard exudate in diabetic macular edema. Yoon CK; Sagong M; Shin JP; Lee SJ; Lee JE; Lee JE; Chung I; Jeong WJ; Pak KY; Kim HW BMC Ophthalmol; 2021 Jan; 21(1):41. PubMed ID: 33451297 [TBL] [Abstract][Full Text] [Related]
4. Predictive capacity of baseline hyperreflective dots on the intravitreal dexamethasone implant (Ozurdex®) outcomes in diabetic macular edema: a multicenter study. Fonollosa A; Zarranz-Ventura J; Valverde A; Becerra E; Bernal-Morales C; Pastor-Idoate S; Zapata MA Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2381-2390. PubMed ID: 31451909 [TBL] [Abstract][Full Text] [Related]
5. Dexamethasone Implants in Diabetic Macular Edema Patients with High Visual Acuity. Sacconi R; Battaglia Parodi M; Casati S; Lattanzio R; Marchini G; Bandello F Ophthalmic Res; 2017; 58(3):125-130. PubMed ID: 28704825 [TBL] [Abstract][Full Text] [Related]
6. Comparison of ranibizumab, aflibercept, and dexamethasone implant monotherapy in treatment-naive eyes with diabetic macular edema: A 12-month real-life experience. Parca O; Cetin EN Indian J Ophthalmol; 2024 May; 72(Suppl 3):S453-S458. PubMed ID: 38648453 [TBL] [Abstract][Full Text] [Related]
7. Quantitative evaluation of hard exudates in diabetic macular edema after short-term intravitreal triamcinolone, dexamethasone implant or bevacizumab injections. Shin YU; Hong EH; Lim HW; Kang MH; Seong M; Cho H BMC Ophthalmol; 2017 Oct; 17(1):182. PubMed ID: 28974211 [TBL] [Abstract][Full Text] [Related]
8. Morphological and functional changes in recalcitrant diabetic macular oedema after intravitreal dexamethasone implant. Iacono P; Parodi MB; Scaramuzzi M; Bandello F Br J Ophthalmol; 2017 Jun; 101(6):791-795. PubMed ID: 27625164 [TBL] [Abstract][Full Text] [Related]
9. Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers. Bonfiglio V; Reibaldi M; Pizzo A; Russo A; Macchi I; Faro G; Avitabile T; Longo A Acta Ophthalmol; 2019 Jun; 97(4):e540-e544. PubMed ID: 30318792 [TBL] [Abstract][Full Text] [Related]
11. Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema. Mahapatra SK; Kumari S Indian J Ophthalmol; 2020 Mar; 68(3):490-493. PubMed ID: 32057010 [TBL] [Abstract][Full Text] [Related]
12. Rapid response to dexamethasone intravitreal implant in diabetic macular edema. Lo Giudice G; Avarello A; Campana G; Galan A Eur J Ophthalmol; 2018 Jan; 28(1):74-79. PubMed ID: 28708221 [TBL] [Abstract][Full Text] [Related]
13. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study. Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA; BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664 [TBL] [Abstract][Full Text] [Related]
14. Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema. Castro-Navarro V; Cervera-Taulet E; Navarro-Palop C; Monferrer-Adsuara C; Hernández-Bel L; Montero-Hernández J BMC Ophthalmol; 2019 Jan; 19(1):15. PubMed ID: 30634940 [TBL] [Abstract][Full Text] [Related]
15. OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant. Zur D; Iglicki M; Busch C; Invernizzi A; Mariussi M; Loewenstein A; Ophthalmology; 2018 Feb; 125(2):267-275. PubMed ID: 28935399 [TBL] [Abstract][Full Text] [Related]
16. COMPARISON OF INTRAVITREAL DEXAMETHASONE IMPLANT AND AFLIBERCEPT IN PATIENTS WITH TREATMENT-NAIVE DIABETIC MACULAR EDEMA WITH SEROUS RETINAL DETACHMENT. Ozsaygili C; Duru N Retina; 2020 Jun; 40(6):1044-1052. PubMed ID: 30950970 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema. Koc H; Alpay A; Ugurbas SH BMC Ophthalmol; 2023 Mar; 23(1):97. PubMed ID: 36915060 [TBL] [Abstract][Full Text] [Related]
18. Vitrectomy Combined with Intraoperative Dexamethasone Implant for the Management of Refractory Diabetic Macular Edema. Kim KT; Jang JW; Kang SW; Chae JB; Cho K; Bae K Korean J Ophthalmol; 2019 Jun; 33(3):249-258. PubMed ID: 31179656 [TBL] [Abstract][Full Text] [Related]
19. Aflibercept vs. dexamethasone implant for recalcitrant diabetic macular edema in pseudophakic eyes - 1-year outcomes from a quazi-randomized study in India. Chakraborty D; Mondal S; Sengupta S; Maiti A; Boral S; Das A; Sinha TK; Nandi K Indian J Ophthalmol; 2024 Jul; 72(7):1001-1006. PubMed ID: 38622856 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Intravitreal Dexamethasone Implants for Treatment of Refractory Diabetic Macular Edema. Unsal E; Eltutar K; Sultan P; Erkul SO; Osmanbasoglu OA Korean J Ophthalmol; 2017 Apr; 31(2):115-122. PubMed ID: 28367039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]